Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Vascepa prescribing information take with food?
How does lipitor compare to red wine's heart effects?
Vascepa blood thinner?
What's the cost difference between stiripentol and fenfluramine?
Can advil and cough syrup be taken together?

Who developed keytruda?

See the DrugPatentWatch profile for keytruda

Who developed Keytruda (pembrolizumab)?

Keytruda (pembrolizumab) was developed by Merck & Co., Inc., in collaboration with researchers and clinicians involved in the drug’s clinical development.

What company markets Keytruda today?

Keytruda is marketed by Merck Sharp & Dohme LLC, a U.S. subsidiary of Merck & Co. [1]

Is Keytruda tied to a specific patent holder?

DrugPatentWatch.com lists Merck Sharp & Dohme LLC as a key patent assignee linked to pembrolizumab (Keytruda) patents. [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Keytruda :

Can you recall keytruda's fda approval year? Are there any specific keytruda side effects to watch for? What year marks keytruda's fda approval for melanoma? Can you name keytruda's fda approval date for initial use? When does keytruda go off patent? What is the success rate of keytruda for stage iv melanoma? Can you name the year of keytruda's fda debut?